Physician profile
Nathan S Mauser
NPI 1245572361
$19,835.37
in general payments reported to CMS, 2019-2025
8 companies · $5,051 in 2025
The $5,051 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,748 · 2020: $1,132 · 2022: $1,047 · 2023: $2,927 · 2024: $3,931 · 2025: $5,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,418.72 |
| Food and Beverage | $1,490.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $5,682.07 | 2019-2023 | Tlif, Xlif |
| Medtronic, INC. | $5,337.40 | 2024-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Cd Horizon Spinal System, Mazor X System |
| Stryker Corporation | $2,057.55 | 2019-2024 | Everest Spinal System |
| Medical Device Business Services, INC. | $1,923.26 | 2019-2025 | Velys |
| Arthrex, INC. | $1,590.09 | 2024 | |
| Globus Medical, INC. | $1,477.65 | 2019 | |
| Prodigy Surgical Distribution, INC. | $1,149.38 | 2024 | |
| Spineology INC. | $617.97 | 2025 | Optimesh Expandable Interbody Fusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Mauser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.